サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1785847

生体吸収性血管足場の世界市場

Bioresorbable Vascular Scaffolds

出版日
ページ情報
英文 265 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.73円
生体吸収性血管足場の世界市場
出版日: 2025年08月07日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 265 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

生体吸収性血管足場の世界市場は2030年までに6億4,000万米ドルに達する見込み

2024年に4億2,250万米ドルと推定される生体吸収性血管足場の世界市場は、2024年から2030年にかけてCAGR 7.2%で成長し、2030年には6億4,000万米ドルに達すると予測されます。本レポートで分析したセグメントの1つである末梢動脈アプリケーションは、CAGR 8.6%を記録し、分析期間終了までに3億7,690万米ドルに達すると予測されています。冠動脈アプリケーションセグメントの成長率は、分析期間中CAGR 5.3%と推定されます。

米国市場は1億1,510万米ドルと推定、中国はCAGR11.5％で成長予測

米国の生体吸収性血管足場市場は、2024年に1億1,510万米ドルと推定されます。世界第2位の経済大国である中国は、2024年から2030年の分析期間においてCAGR 11.5%で推移し、2030年には1億3,620万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.5％と7.0％と予測されています。欧州では、ドイツがCAGR 4.8%で成長すると予測されています。

世界の生体吸収性血管足場市場- 主要動向と促進要因のまとめ

生体吸収性血管足場が心血管治療で勢いを増す理由とは？

生体吸収性血管足場（BVS）は、時間の経過とともに自然に溶けて治癒した血管を残す一時的な構造的解決策を提供することで、冠動脈疾患（CAD）の治療に革命をもたらしています。動脈内に永久に留まる従来の金属製ステントとは異なり、生体吸収性スキャフォールドは重要な治癒期に機械的サポートを提供し、その後徐々に分解して自然な血管機能を回復するように設計されています。この次世代技術は、ステント後期の血栓症、血管の籠り、炎症など、永久ステントに伴う長期的な合併症に対処するものです。

心血管系疾患の世界の蔓延は、低侵襲治療への需要の高まりと相まって、生体吸収性血管足場の採用を後押ししています。患者や心臓専門医は、長期的な転帰を改善し、繰り返し介入する必要性を減らす可能性があることから、これらのデバイスをますます支持するようになっています。さらに、ポリマー科学と生体吸収性金属合金の進歩により、足場強度、分解制御、生体適合性が向上しており、BVSは従来のステントに代わる有望な選択肢となっています。ヘルスケア・システムが患者中心で費用対効果の高いソリューションを優先する中、BVSはインターベンショナル・カーディオロジーにおける重要な技術革新として台頭しつつあります。

技術の進歩はどのように生体吸収性血管足場を改善しているのか？

生体材料、足場設計、薬剤溶出技術の革新が生体吸収性血管足場の進化を促し、安全性、有効性、臨床性能を向上させています。この分野における最も重要な進歩のひとつは、ポリL乳酸（PLLA）のような高強度生体吸収性ポリマーの開発であり、これは経時的な分解を抑制しながら十分な半径方向の支持を提供します。さらに、研究者らは、機械的強度が向上し、吸収が速く、動脈内にポリマーが長期間存在することに関連する懸念を軽減するマグネシウムベースの生体吸収性足場を研究しています。

もう1つの画期的な進歩は、初期の治癒期にシロリムスやエベロリムスなどの抗増殖剤を放出することによって再狭窄を予防する薬剤溶出性コーティングを組み込んだことです。これらの薬剤溶出性生体吸収性スキャフォールドは、最適な血管治癒を確保しながらステント内再狭窄率を低下させることで、有望な臨床結果を示しています。さらに、計算モデリングとAIを駆使した最適化技術により、スキャフォールドの設計が強化され、ストラットのプロファイルが薄くなり、柔軟性が向上して、スキャフォールド血栓症などの合併症が減少しています。このような技術の進歩によりBVSの性能はさらに向上しており、インターベンショナル・カーディオロジーでは次世代デバイスの採用が加速すると予想されます。

生体吸収性血管足場業界の成長を牽引する市場動向は？

冠動脈疾患の有病率の増加と経皮的冠動脈インターベンション（PCI）件数の増加は、生体吸収性血管足場市場の成長を促進する最も重要な動向の一つです。心血管疾患は依然として世界の死亡の主因であるため、ヘルスケアプロバイダーは患者の長期的な転帰を改善する革新的なソリューションを優先しています。BVSの需要はまた、低侵襲で患者に優しい治療法へのシフトによっても牽引されており、生体吸収性技術は長期的な体内異物存在の低減という広範な目標に合致しています。

市場を形成するもう一つの重要な動向は、生体吸収性スキャフォールドに対する規制当局の支持の高まりです。旧世代のBVSは足場の血栓症や最適とは言えない分解速度に対する懸念に直面していたが、材料科学や臨床データにおける最近の技術革新により、規制当局やヘルスケア専門家の関心が再び高まっています。さらに、生体吸収性技術が冠動脈インターベンションにとどまらず、末梢動脈疾患（PAD）やその他の血管疾患にも拡大したことで、新たな市場機会が開かれつつあります。臨床試験でBVSの有用性が検証され続け、さらに多くの次世代デバイスが規制当局の承認を受けるにつれて、市場は先進経済諸国と新興経済諸国の両方で大きく拡大する態勢が整っています。

生体吸収性血管足場市場の将来を形作る主な成長促進要因は何か？

生体吸収性血管足場市場の成長は、技術の進歩、臨床採用の増加、患者の長期的転帰の重視の高まりなど、複数の要因によってもたらされます。主な成長要因の1つは、革新的で効果的な治療オプションを必要とする心血管疾患の負担増です。患者集団の拡大、特に高齢化層や高リスク群では、生体吸収性スキャフォールドに対する需要の増加が見込まれています。

市場を形成するもう一つの重要な促進要因は、医療機器企業や学術機関による研究開発（R&D）への旺盛な投資です。スキャフォールドの設計、吸収速度論、薬剤溶出機能の継続的な改善により、BVS技術の臨床的実現可能性が高まっています。さらに、ヘルスケアプロバイダー、医療機関、バイオテクノロジー企業間の戦略的提携により、最先端の生体吸収性スキャフォールドの商業化が加速しています。また、短期的な処置コストよりも長期的な患者の利益を優先する価値ベースのヘルスケアモデルの採用が増加していることも、BVSの需要を押し上げると予想されます。これらの要因によって技術革新と採用が促進され続ける中、生体吸収性血管足場は冠動脈および末梢動脈疾患管理の将来を再定義し、長期的なヘルスケアコストを削減しながら患者の転帰を改善することになるでしょう。

セグメント

用途（末梢動脈用途、冠動脈用途）、最終用途（病院最終用途、外来治療センター（ACS）最終用途、専門クリニック最終用途）

調査対象企業の例

  • Abbott Cardiovascular
  • BD
  • Biotronik AG
  • Boston Scientific Corporation
  • Elixir Medical Corporation
  • Kyoto Medical Planning Co., Ltd
  • Meril Life Sciences
  • MicroPort
  • Reva Medical Inc
  • Shandong Huaan Biotechnology Co.,Ltd
  • Terumo Interventional Systems
  • W. L. Gore & Associates, Inc.
  • Zeus Inc

AI統合

当社は、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP29609

Global Bioresorbable Vascular Scaffolds Market to Reach US$640.0 Million by 2030

The global market for Bioresorbable Vascular Scaffolds estimated at US$422.5 Million in the year 2024, is expected to reach US$640.0 Million by 2030, growing at a CAGR of 7.2% over the analysis period 2024-2030. Peripheral Artery Application, one of the segments analyzed in the report, is expected to record a 8.6% CAGR and reach US$376.9 Million by the end of the analysis period. Growth in the Coronary Artery Application segment is estimated at 5.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$115.1 Million While China is Forecast to Grow at 11.5% CAGR

The Bioresorbable Vascular Scaffolds market in the U.S. is estimated at US$115.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$136.2 Million by the year 2030 trailing a CAGR of 11.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.5% and 7.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.

Global Bioresorbable Vascular Scaffolds Market - Key Trends & Drivers Summarized

Why Are Bioresorbable Vascular Scaffolds Gaining Momentum in Cardiovascular Treatments?

Bioresorbable vascular scaffolds (BVS) are revolutionizing the treatment of coronary artery disease (CAD) by offering a temporary structural solution that naturally dissolves over time, leaving behind a healed vessel. Unlike traditional metallic stents, which remain permanently in the artery, bioresorbable scaffolds are designed to provide mechanical support during the critical healing phase and then gradually degrade, restoring natural vessel function. This next-generation technology addresses long-term complications associated with permanent stents, such as late-stent thrombosis, vessel caging, and inflammation.

The growing global prevalence of cardiovascular diseases, coupled with the increasing demand for minimally invasive procedures, has propelled the adoption of bioresorbable vascular scaffolds. Patients and cardiologists are increasingly favoring these devices due to their potential to improve long-term outcomes and reduce the need for repeat interventions. Additionally, advancements in polymer science and bioresorbable metal alloys are enhancing scaffold strength, degradation control, and biocompatibility, making BVS a promising alternative to traditional stents. As healthcare systems prioritize patient-centric and cost-effective solutions, BVS is emerging as a key innovation in interventional cardiology.

How Are Technological Advancements Improving Bioresorbable Vascular Scaffolds?

Innovations in biomaterials, scaffold design, and drug-eluting technology are driving the evolution of bioresorbable vascular scaffolds, improving their safety, efficacy, and clinical performance. One of the most significant advancements in this field is the development of high-strength bioresorbable polymers, such as poly-L-lactic acid (PLLA), which provide sufficient radial support while ensuring controlled degradation over time. Additionally, researchers are exploring magnesium-based bioresorbable scaffolds that offer improved mechanical strength and faster resorption, reducing concerns related to prolonged polymer presence in the arteries.

Another major breakthrough is the incorporation of drug-eluting coatings that help prevent restenosis by releasing antiproliferative agents such as sirolimus or everolimus during the initial healing phase. These drug-eluting bioresorbable scaffolds have demonstrated promising clinical outcomes by reducing in-stent restenosis rates while ensuring optimal vascular healing. Furthermore, computational modeling and AI-driven optimization techniques are enhancing scaffold design, leading to thinner strut profiles and improved flexibility, which reduce complications such as scaffold thrombosis. As these technological advancements continue to refine BVS performance, the adoption of these next-generation devices is expected to accelerate in interventional cardiology.

Which Market Trends Are Driving Growth in the Bioresorbable Vascular Scaffolds Industry?

The increasing prevalence of coronary artery disease and the rising number of percutaneous coronary interventions (PCIs) are among the most significant trends fueling the growth of the bioresorbable vascular scaffold market. With cardiovascular diseases remaining the leading cause of mortality worldwide, healthcare providers are prioritizing innovative solutions that improve long-term patient outcomes. The demand for BVS is also being driven by a shift toward minimally invasive and patient-friendly interventions, where bioresorbable technology aligns with the broader goal of reducing long-term foreign material presence in the body.

Another key trend shaping the market is the increasing regulatory support for bioresorbable scaffolds. While earlier-generation BVS faced concerns over scaffold thrombosis and suboptimal degradation rates, recent innovations in material science and clinical data have led to renewed interest from regulatory agencies and healthcare professionals. Additionally, the expansion of bioresorbable technology beyond coronary interventions-into peripheral artery disease (PAD) and other vascular conditions-is opening new market opportunities. As clinical trials continue to validate the benefits of BVS, and more next-generation devices receive regulatory approvals, the market is poised for significant expansion in both developed and emerging economies.

What Are the Key Growth Drivers Shaping the Future of the Bioresorbable Vascular Scaffolds Market?

The growth in the bioresorbable vascular scaffold market is driven by multiple factors, including technological advancements, increasing clinical adoption, and a growing emphasis on long-term patient outcomes. One of the primary growth drivers is the rising burden of cardiovascular diseases, which necessitates innovative and effective treatment options. As patient populations expand, particularly in aging demographics and high-risk groups, the demand for bioresorbable scaffolds is expected to increase.

Another crucial driver shaping the market is the strong investment in research and development (R&D) by medical device companies and academic institutions. Continuous improvements in scaffold design, resorption kinetics, and drug-eluting capabilities are enhancing the clinical feasibility of BVS technology. Additionally, strategic collaborations between healthcare providers, medical institutions, and biotech firms are accelerating the commercialization of advanced bioresorbable scaffolds. The increasing adoption of value-based healthcare models, which prioritize long-term patient benefits over short-term procedural costs, is also expected to boost the demand for BVS. As these factors continue to drive innovation and adoption, bioresorbable vascular scaffolds are set to redefine the future of coronary and peripheral artery disease management, improving patient outcomes while reducing long-term healthcare costs.

SCOPE OF STUDY:

The report analyzes the Bioresorbable Vascular Scaffolds market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Peripheral Artery Application, Coronary Artery Application); End-Use (Hospitals End-Use, Ambulatory Care Centers (ACS) End-Use, Specialty Clinics End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • Abbott Cardiovascular
  • BD
  • Biotronik AG
  • Boston Scientific Corporation
  • Elixir Medical Corporation
  • Kyoto Medical Planning Co., Ltd
  • Meril Life Sciences
  • MicroPort
  • Reva Medical Inc
  • Shandong Huaan Biotechnology Co.,Ltd
  • Terumo Interventional Systems
  • W. L. Gore & Associates, Inc.
  • Zeus Inc

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Bioresorbable Vascular Scaffolds - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Burden of Cardiovascular Diseases Throws the Spotlight on Bioresorbable Vascular Scaffolds as a Revolutionary Stent Alternative
    • Shift Toward Minimally Invasive and Restorative Therapies Drives Demand for BVS in Coronary Interventions
    • Clinical Preference for Temporary Vessel Support Solutions Strengthens the Business Case for Bioresorbable Scaffolds
    • Limitations of Traditional Drug-Eluting Stents (DES) Expand Addressable Market Opportunity for BVS Technologies
    • Growing Emphasis on Natural Vessel Healing and Long-Term Vascular Restoration Fuels Adoption of BVS Devices
    • Technological Advancements in Polymer and Magnesium-Based Materials Propel Innovation in Scaffold Design and Performance
    • Increasing Use of Intravascular Imaging Techniques Enhances Precision Deployment and Optimized Outcomes of BVS
    • Rising Focus on Reducing Late-Stent Thrombosis Risk Spurs Clinical Interest in Fully Resorbable Scaffold Solutions
    • Next-Generation BVS Systems with Improved Radial Strength and Resorption Kinetics Accelerate Clinical Acceptance
    • Surge in Demand for Scaffold Solutions in Younger Patient Populations Propels Growth of Bioresorbable Stent Adoption
    • Healthcare System Focus on Reducing Long-Term Reintervention Rates Supports Broader Adoption of BVS
    • Emergence of Hybrid Scaffolds and Drug-Eluting Bioresorbable Technologies Opens New Avenues for Competitive Differentiation
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Bioresorbable Vascular Scaffolds Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Bioresorbable Vascular Scaffolds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Bioresorbable Vascular Scaffolds by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Peripheral Artery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Peripheral Artery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Peripheral Artery Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Coronary Artery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Coronary Artery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Coronary Artery Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Ambulatory Care Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Ambulatory Care Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Ambulatory Care Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Bioresorbable Vascular Scaffolds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: USA 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: USA 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: Canada 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: Canada 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • JAPAN
    • Bioresorbable Vascular Scaffolds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 29: Japan Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Japan Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Japan 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Japan 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • CHINA
    • Bioresorbable Vascular Scaffolds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 35: China Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: China Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: China 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: China 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • EUROPE
    • Bioresorbable Vascular Scaffolds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 41: Europe Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 42: Europe Historic Review for Bioresorbable Vascular Scaffolds by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Europe 15-Year Perspective for Bioresorbable Vascular Scaffolds by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Europe 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • FRANCE
    • Bioresorbable Vascular Scaffolds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 50: France Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: France Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: France 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 53: France Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: France 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • GERMANY
    • Bioresorbable Vascular Scaffolds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 56: Germany Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Germany Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Germany 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Germany 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 62: Italy Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Italy Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Italy 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Italy 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Bioresorbable Vascular Scaffolds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 68: UK Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: UK Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: UK 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 71: UK Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: UK 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 74: Spain Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Spain Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Spain 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Spain 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 80: Russia Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Russia Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Russia 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Russia 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Rest of Europe 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Bioresorbable Vascular Scaffolds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Bioresorbable Vascular Scaffolds by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Asia-Pacific 15-Year Perspective for Bioresorbable Vascular Scaffolds by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Bioresorbable Vascular Scaffolds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 101: Australia Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Australia Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Australia 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Australia 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • INDIA
    • Bioresorbable Vascular Scaffolds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 107: India Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: India Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: India 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 110: India Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: India 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 113: South Korea Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: South Korea Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: South Korea 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: South Korea 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 119: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Rest of Asia-Pacific Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Rest of Asia-Pacific 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Bioresorbable Vascular Scaffolds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 125: Latin America Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 126: Latin America Historic Review for Bioresorbable Vascular Scaffolds by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Latin America 15-Year Perspective for Bioresorbable Vascular Scaffolds by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Latin America 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 134: Argentina Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Argentina Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Argentina 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Argentina 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 140: Brazil Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Brazil Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Brazil 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Brazil 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 146: Mexico Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Mexico Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Mexico 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Mexico 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 152: Rest of Latin America Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of Latin America Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Rest of Latin America 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Bioresorbable Vascular Scaffolds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 158: Middle East Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 159: Middle East Historic Review for Bioresorbable Vascular Scaffolds by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Middle East 15-Year Perspective for Bioresorbable Vascular Scaffolds by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Middle East 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 167: Iran Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Iran Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Iran 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Iran 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 173: Israel Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Israel Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Israel 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Israel 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 179: Saudi Arabia Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Saudi Arabia Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Saudi Arabia 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 185: UAE Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: UAE Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: UAE 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: UAE 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 191: Rest of Middle East Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Middle East Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Middle East 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • AFRICA
    • Bioresorbable Vascular Scaffolds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 197: Africa Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Africa Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Africa 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Africa 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030

IV. COMPETITION